Minority Diabetes Reports
Thursday, November 29th, 2012
Jamanetwork: Nov 26, 2012 Early detection of diabetic retinopathy (DR) is crucial to prevent blindness. Timely intervention with laser therapy can reduce the risk of severe vision loss by more than 90%.1 Despite well-accepted national and international guidelines, on average, less than 50% of patients with diabetes mellitus (DM) undergo screening for retinopathy in the United States.2– 3 Barriers […]
Minority Diabetes Reports
Thursday, November 29th, 2012
Jamanetwork: Nov 26, 2012 Communication between African American patients and white health care providers has been shown to be of poorer quality when compared with race-concordant patient-provider communication. Fear on the part of patients that providers stereotype them negatively might be one cause of this poorer communication. This stereotype threat may be lessened by a values-affirmation […]
Clinical Trial News
Thursday, November 29th, 2012
Science Salsa: Nov. 14, 2012 November 14th was world diabetes day, a day to mark on your calendar! Diabetes complications drastically affect your quality of life and cut your life expectancy. Some risk factors such as age and ethnicity are unavoidable, but type 2 diabetes is often preventable and can be treated by changing what you eat and by exercising […]
Minority Diabetes Reports
Thursday, November 29th, 2012
ADA: August 24, 2012 Several studies have identified nearly 40 different type 2 diabetes susceptibility loci, mainly in European populations, but few of them have been evaluated in the Mexican population. The aim of this study was to examine the extent to which 24 common genetic variants previously associated with type 2 diabetes are associated […]
Clinical Trial News
Thursday, November 29th, 2012
A systematic review and meta-analysis of behavioral interventions Diabetes Care: December 1, 2012 OBJECTIVE Behavioral interventions targeting “free-living” physical activity (PA) and exercise that produce long-term glycemic control in adults with type 2 diabetes are warranted. However, little is known about how clinical teams should support adults with type 2 diabetes to achieve and sustain a physically […]
Clinical Trial News
Thursday, November 29th, 2012
Meta-analysis of randomized controlled trials Diabetes Care: December 1, 2012 OBJECTIVE We compared the effect of insulin lispro protamine suspension (ILPS) with that of insulin glargine and insulin detemir, all given as basal supplementation, in the treatment of patients with type 2 diabetes. RESEARCH DESIGN AND METHODS We conducted an electronic search until February 2012, including online registries […]
Clinical Trial News
Thursday, November 29th, 2012
JCEM: November 21, 2012 Childhood obesity is increasingly associated with type 2 diabetes (T2D). Metformin reduces the risk for T2D in adult obese nondiabetic patients, but the evidence in obese children and young people is inconclusive. Objective: The objective of the study was to assess the effect of metformin on body mass index SD score (BMI-SDS), metabolic risk factors, […]
Clinical Trial News
Thursday, November 29th, 2012
Diabetes Care: November 19, 2012 OBJECTIVE To characterize glucose response patterns of people who wore a real-time continuous glucose monitor (RT-CGM) as an intervention to improve glycemic control. Participants had type 2 diabetes, were not taking prandial insulin, and interpreted the RT-CGM data independently. RESEARCH DESIGN AND METHODS Data were from the first 12 weeks of a 52-week, […]
Clinical Trial News
Thursday, November 29th, 2012
Phrma: 11/26/12 Many times, we have written in this space about clinical trials of new medicines and how they are beneficial not only to patients, but also the economy and the advancement of science and patient care. But it’s time to play a little catch-up and focus on a specific clinical trial, its key clinician and his institution […]
News
Thursday, November 29th, 2012
Dynamic modeling of incidence, mortality, and population growth ADA: 12/1/12 OBJECTIVE To forecast the number of U.S. individuals aged <20 years with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) through 2050, accounting for changing demography and diabetes incidence. RESEARCH DESIGN AND METHODS We used Markov modeling framework to generate yearly forecasts of the […]
